2018
Serial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system
Barreira G, Costa J, Costa R, Staico R, Chamie D, Slhessarenko J, Tanajura L, Abizaid A, Sousa A, Abizaid A. Serial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system. Catheterization And Cardiovascular Interventions 2018, 92: e368-e374. PMID: 29521477, DOI: 10.1002/ccd.27591.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAgedCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery DiseaseCoronary VesselsFemaleHumansMacrolidesMaleMiddle AgedPercutaneous Coronary InterventionPredictive Value of TestsProspective StudiesTime FactorsTreatment OutcomeUltrasonography, InterventionalConceptsBioresorbable coronary scaffoldsSafety of coronary angioplastySuppression of neointimal proliferationAdverse cardiac eventsTime pointsLate lumen lossNon-randomized studiesPercutaneous coronary interventionDevice dimensionsIntravascular ultrasound evaluationScaffold systemConsecutive patientsCoronary scaffoldsPrimary endpointSingle-centerCardiac eventsAngiographic successUltrasound evaluationFollow-upLumen lossCoronary interventionSerial evaluationNeointimal proliferationScaffold areaCoronary angioplasty
2013
TCT-419 Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions
Souza R, Costa R, Verheye S, Schofer J, Costa J, Chamié D, Abizaid A, John Y, Bbhat V, Morrison L, Toyloy S, Abizaid A. TCT-419 Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions. Journal Of The American College Of Cardiology 2013, 62: b130. DOI: 10.1016/j.jacc.2013.08.1159.Peer-Reviewed Original ResearchScaffold systemTCT-596 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial
Costa J, Schofer J, Verheye S, Toyloy S, Chamié D, Bbhat V, Costa R, Witzenbichler B, Morrison L, Yan J, Sousa A, Sousa J, Abizaid A. TCT-596 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial. Journal Of The American College Of Cardiology 2013, 62: b181. DOI: 10.1016/j.jacc.2013.08.1343.Peer-Reviewed Original ResearchScaffold system
2012
TCT-302 Evaluation of the Novel DESolve Myolimus-Eluting Bioresorbable Coronary Scaffold System for Treatment of De Novo Coronary Arteries: Six-Month Optical Coherence Tomography Results from the DESolve FIM Trial
Chamie D, Costa J, Abizaid A, Webster M, Stewart J, Costa R, Yan J, bhat V, morrison L, Toyloy S, Ormiston J, Verheye S. TCT-302 Evaluation of the Novel DESolve Myolimus-Eluting Bioresorbable Coronary Scaffold System for Treatment of De Novo Coronary Arteries: Six-Month Optical Coherence Tomography Results from the DESolve FIM Trial. Journal Of The American College Of Cardiology 2012, 60: b86. DOI: 10.1016/j.jacc.2012.08.326.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply